Related Experiment Video

Updated: Aug 17, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

[Primary T-cell lymphoma of the pancreas in children]

Nadia Aloui-Kasbi1, Samia Mbarek, Ibtissem Bellagha

  • 1Service de Radiologie, Hôpital d'enfants de Tunis.

La Tunisie Medicale
|June 23, 2005
PubMed

Insights

Primary pancreatic lymphoma, a rare non-Hodgkin's T-cell lymphoma, occurred in an 11-year-old boy presenting with epigastric pain and fever. Despite imaging, the aggressive cancer led to rapid decline and death from severe infection.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pediatric Hematology/Oncology

Background:

  • Non-Hodgkin's lymphoma commonly involves the gastrointestinal tract as an extranodal site.
  • Primary pancreatic lymphoma is an exceptionally rare presentation of non-Hodgkin's lymphoma.

Observation:

  • An 11-year-old boy presented with epigastric pain and fever.
  • Imaging studies including sonography, CT, and MRI revealed a pancreatic lesion.
  • The lesion was diagnosed as high-grade primary non-Hodgkin's T-cell lymphoma originating from the pancreas.

Findings:

  • The patient had a rare case of primary pancreatic non-Hodgkin's T-cell lymphoma.
  • The high-grade lymphoma was aggressive and rapidly progressive.

Implications:

  • This case highlights the importance of considering rare pancreatic malignancies in pediatric patients with abdominal symptoms.
  • Early diagnosis and understanding the aggressive nature of primary pancreatic lymphoma are crucial.
  • Further research into the pathogenesis and treatment of this rare condition is warranted.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...